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Background: Atypical spinal tuberculosis (TB) usually presents in a slowly indolent manner
with  nonspeciﬁc clinical presentations making the diagnosis a great challenge for physi-
cians.  New technologies for the detection of atypical spinal TB are urgently needed. The aim
of this study was to assess the diagnostic value of an enzyme-linked immunospot (ELISPOT)
assay  in clinically suspected cases of atypical spinal TB in China.
Methods:  From March 2011 to September 2012, a total of 65 patients with suspected atypical
spinal  TB were enrolled. In addition to conventional tests for TB, we  used ELISPOT assays to
measure the IFN- response to ESAT-6 and CFP-10 in T-cells in samples of peripheral blood
mononuclear  cells. Patients with suspected atypical spinal TB were  classiﬁed by diagnostic
category.  Data on clinical characteristics of the patients and conventional laboratory results
were  collected.
Results: Out of 65 patients, 4 were excluded from the study. 18 (29.5%) subjects had culture-
conﬁrmed  TB, 11 (18.0%) subjects had probable TB, and the remaining 32 (52.5%) subjects did
not have TB. Generally, the features of atypical spinal TB include the following aspects: (1)
worm-eaten  destruction of vertebral endplate; (2) destruction of centricity of the vertebral
body  or concentric collapse of vertebral body; (3) tuberculous abscess with no identiﬁable
osseous  lesion; (4) contiguous or skipped vertebral body destruction. 26 patients with atyp-
ical spinal TB had available biopsy or surgical specimens for histopathologic examination
and  23 (88.5%) specimens had pathologic features consistent with TB infection. The sensitiv-
ities  of the PPD skin test and ELISPOT assay for atypical spinal TB were  58.6% and 82.8%, and
their  speciﬁcities were 59.4% and 81.3%, respectively. Malnutrition and age were  associatedwith  ELISPOT positivity in atypical spinal TB patients.Conclusions: The ELISPOT 
spinal  TB.
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Introduction
Spinal tuberculosis (TB) has been an important public health
issue,  having serious medical, social and ﬁnancial impacts,
especially in developing countries.1 Skeletal TB occurs in
10%  of extrapulmonary manifestations, of which spinal TB
accounts  for approximately 50%.2,3 The typical clinical pre-
sentation  of a patient with spinal TB is back pain, kyphotic
deformity, and in some cases a cold abscess.4 On plain radio-
graphs,  the classical spinal TB affected anterior aspect of the
vertebral  body as well as the disk leading to destruction of
adjacent  vertebral bodies, intervertebral disk and even soft
tissues.5 However, a small number of cases do not have the
typical  characteristics of spinal TB. Atypical spinal tuberculo-
sis  can be classiﬁed into atypical radiographic presentation
and  atypical clinical presentation.4 Actually, these kinds of
atypical  spinal TB are a great challenge to physicians because
of  the nonspeciﬁc and wide spectrum of clinical presentations
that  result in delay of diagnosis and risk of signiﬁcant potential
morbidity  and mortality due to several complications. Early
diagnosis  and treatment is the key to avoiding this long-term
disability.6,7 Therefore, we  urgently need a faster, more  sensi-
tive,  and speciﬁc test for the diagnosis of atypical spinal TB in
clinical practice.
Recently, an enzyme-linked immunospot (ELISPOT) assay
using  pools of early secretory antigenic target 6 (ESAT-6) and
culture  ﬁltrate protein 10 (CFP-10) peptides was manufactured
and  commercialized (Oxford Immunotec, Oxford, UK).8 It is
based  on the detection of interferon-gamma (IFN-) released
by  activated T lymphocytes. The stimulants used, ESAT-6 and
CFP-10  peptides, are located within the region of difference
1  (RD1) of the Mycobacterium tuberculosis and Mycobacterium
bovis genomes, but is absent from all strains of M. bovis BCG,
as  well as from most NTM.9,10 The ELISPOT assay has been
demonstrated to be useful for the diagnosis of skeletal TB.11,12
However, few studies have investigated the sensitivity and
speciﬁcity  of this assay for diagnosing atypical spinal TB. The
aim  of this study was  to assess the diagnostic value of the
ELISPOT  assay in clinically suspected cases of atypical spinal
TB.
Materials  and  methods
Setting  and  patients
This study was  simultaneously conducted at three academic
hospitals  (Nanfang Hospital, Southern Medical University, an
1800-bed medical center in southern China; Guangzhou tho-
racic  hospital, a 600-bed medical center in southern China;
and  Guangdong hospital of traditional Chinese medicine, a
2000-bed medical center in southern China). The study proto-
col  adhered to the Declaration of Helsinki, and was  approved
by  the Medical Ethics Committee of Nanfang Hospital, South-
ern  Medical University. Patients were informed verbally and
in  writing of the potential beneﬁts and risks of the study,
and  all patients signed an informed consent. After writ-
ten  consent had been obtained, all patients with suspected
atypical spinal TB were  prospectively enrolled from March
2011  to September 2012. Data on clinical characteristics of 1 3;1  7(5):529–537
the patients and conventional laboratory results were col-
lected.  All cases were independently classiﬁed by three of
the  study investigators (Qiang Zhang, Shuchai Xu and Jiant-
ing  Chen) who were blinded to the results of the ELISPOT
assay. Classiﬁcation was  based on clinical, histopathologi-
cal, radiological, and microbiological information. Atypical
spinal  TB had been classiﬁed into atypical radiographic
presentation and atypical clinical presentation according
to  the criteria as follows4: (1) single vertebral disease; (2)
multiple  vertebral disease; (3) presentation as prolapsed inter-
vertebral  disk or failed back syndrome; (4) cold abscess
without obvious bony lesion; (5) tubercular granulomas.
Exclusion criteria: eliminating spinal TB patients with the
typical  presentation (lesion affecting the anterior part of
two  or more  continuous vertebral levels and causes nar-
rowing  of the adjacent disk space and bone destruction).5
All patients were ﬁnally deemed to have conﬁrmed tuber-
culosis  if the clinical specimens on culture was  positive for
M.  tuberculosis. Patients were classiﬁed as having probable
TB  if histopathological ﬁndings of a biopsy specimen were
consistent with the diagnosis of TB infection (granuloma-
tous inﬂammation and/or caseating necrosis) and if they
responded clinically and radiologically to a full course of anti-
TB  treatment, or as not having TB if another diagnosis was
made  or if there was  clinical improvement without anti-TB
therapy.13–15
Laboratory  procedures  and  histopathology
Microbiologic and pathologic specimens for diagnosing atyp-
ical  spinal TB were processed by standard techniques and
procedures. In brief, mycobacteria were  cultured on solid cul-
ture  medium. Smears of decontaminated specimens were
stained  with the Ziehl-Neelsen stain and examined for acid-
fast  bacilli (AFB). The culture showing AFB was identiﬁed as M.
tuberculosis  complex with a commercial DNA probe (AccuProbe
Mycobacterium complex culture identiﬁcation kit; GenProbe;
San  Diego, CA). If the AccuProbe assay was negative, cultures
were  identiﬁed with a commercially available PCR test for NTM
(Gaoteng,  Nanchang, China). For histopathological examina-
tion,  formalin-ﬁxed and parafﬁn-embedded tissue blocks of
biopsied  specimens were stained with hematoxylin–eosin
stain.
Blood  ELISPOT  assays
The ELISPOT assays (T-SPOT.TB; Oxford Immunotec Ltd.) were
performed according to the manufacturer’s recommenda-
tions. 4–5 ml  of venous blood samples taken from the study
participants in heparinized glass tubes, and peripheral blood
mononuclear cells (PBMC) were  isolated and quantiﬁed at sec-
ond day after the patients went into hospital. Brieﬂy, 250,000
PBMCs  were  plated for 18 h on 96-well plates, which had
been  pre-coated with a mouse anti-human IFN- antibody per
well.  The cells were  left unstimulated (negative control) or
were  stimulated with 50 l PHA (positive control), with 50 l
ESAT-6  and CFP-10 peptides in separate wells. The response
of  stimulated cultures was considered positive when one
or  both test wells contained at least six more  spots than
the  negative control wells or had at least twice as many  as
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Patients with suspected atypical spinal TB
(n=65)
Valid ELISPOT results
(n=61)
4 patients excluded from analyses
2 did not complete ELISPOT
2 had indeterminate diagnosis
Positive-ELISPOT
(n=30)
Definite TB
(n=24)
ELISPOT vs PPD
(n=61) ELISPOT vs Serological test
(n=61)
Definite TB
(n=5)
Non-TB
(n=6)
Non-TB
(n=26)
Negative-ELISPOT
(n=31)
Fig. 1 – Study ﬂow diagram of atypical spinal tuberculosis.
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cpot-forming cells (SFC) as the negative control wells. The
umber of SFC in each well was  automatically counted with
 CTL-ImmunoSpot® S5 Versa Analyzer (Cellular Technology
td.,  USA).
PD  skin  test  and  serological  (antibody  detection)  test
PD produced from M. tuberculosis (50 IU/ml) was  purchased
rom  Guangzhou Longcheng Technology Inc., China. All
atients  with suspected atypical spinal TB were injected intra-
ermally  in the left forearm with 0.1 ml  of 5 IU PPD (Mantoux
echnique) after extraction of blood for the ELISPOT assay.
he  diameters of both axes of skin induration were mea-
ured  and recorded by a certiﬁed doctor 72 h after antigen
njection. Results were expressed as the mean of the diame-
er  of induration in millimeters. A positive result was deﬁned
s  an induration ≥5 mm in diameter. Serological (antibody
etection) test for atypical spinal TB was  identiﬁed with a
ommercially antibody (IgG) detection kit (Yaji Inc., Shanghai,
hina).
ate  management  and  statistical  analyses
ll data were  entered into a Microsoft Ofﬁce Excel ﬁle.
ensitivity, speciﬁcity, positive predictive value (PPV) and
egative  predictive value (NPV) were calculated to evalu-
te  diagnostic performance for the ELISPOT and PPD skin
est.  Analyses were  performed using the commercial sta-
istical  software SPSS version 13.0 (SPSS Inc., Chicago, IL,
SA).  2 test or Fisher’s exact test were  used in contingency
nalyses. Mann–Whitney U test was  used to compare non-
arametric distribution of the SFC among different groups.
he  agreement beyond chance between the ELISPOT assay
nd  the routine tuberculosis examination were assessed
sing  the appa () coefﬁcient. Agreement was  considered
oor if  < 0.2, fair if  < 0.4, moderate if  < 0.6, substantial
f  < 0.8 or good if  > 0.8.16 All tests of signiﬁcance were
wo-tailed, and p < 0.05 was  considered statistically signiﬁ-
ant.Results
Demographics  and  clinical  characteristics
A total of 65 patients with suspected atypical spinal TB were
recruited  during the study period. Four patients were  excluded
from  the study, among which two did not complete the
ELISPOT  assay and two had no ﬁnal diagnosis. The remaining
61  patients were ultimately included for ELISPOT analyses
(Fig.  1). The clinical characteristics of these 61 patients are
summarized in Table 1. A diagnosis of TB (18 conﬁrmed cases,
11  probable cases) was  made in 29 patients (47.5%), and the
remaining  32 patients (52.5%) did not have TB. The mean age
(±standard  deviation) of the patients with and without TB
was  32.4 ± 14.9 and 47.9 ± 11.2 years, respectively. All patients
enrolled  in the present study were  tested for HIV by sero-
logy  and all had negative results. The median disease time
course  (±standard deviation) of atypical spinal TB patients
was  9.7 ± 7.1 months.
Clinical  presentation  and  imaging  study  ﬁndings
The clinical presentations of atypical spinal TB patients are
summarized  in Table 2. Back pain was  the most common clin-
ical  complaint (24 patients, 82.8%), followed by tenderness
(10  patients, 34.5%). Neurological deﬁcit was  found in one
patient.  All patients received an X-ray, computed tomography
(CT)  scan and/or magnetic resonance imaging (MRI) exam-
ination.  Radionuclide bone scanning was  performed in ﬁve
patients  (17.2%), all of whom had foci of increased uptake.
Through the imaging study, worm-eaten destruction of ver-
tebral  endplate was seen in ﬁve patients (Fig. 2). Destruction
of  centricity of the single vertebral body or concentric col-
lapse  of single vertebral body was  seen in ﬁve patients (Fig. 3).
Fifteen patients presented contiguous or skipped vertebral
body  destruction. Tuberculous abscess with no identiﬁable
osseous lesion were visible by CT and MRI  in four patients
(Fig.  4).
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Table 1 – Clinical characteristics in 61 patients with suspected atypical spinal TB.
Characteristics Total (n = 61) Deﬁnite-TB (n = 29) Non-TB (n = 32)a
Mean age (mean ± SD), range 40.5 ± 15.2 (3–68) 32.4 ± 14.9 (3–60) 47.9 ± 11.2 (26–68)
Male/female 29/32 15/14 14/18
Underlying condition or illness (%)
Hypertension  7 1 6
Pneumonia 0 0 0
Hepatitis B 2 2 0
Syphilis 1 1 0
Diabetes 1 0 1
Rheumatoid arthritis 4 4 0
Immunocompromised conditionb (%) 4  3 1
Presence of TB contact 8 3 5
Combined pulmonary TB (%) 3 2 1
Previous history of TB treatment (%) before recruitment 2 1 1
Data are presented as number.
a Non-TB (3 patients, Lumbar Disk Herniation; 5 patients, Spinal Canal Tumor; 10 patients, Spinal Tumor; 3 patients, Suppurative Spondylitis;
4 patients, Spondylitis caused by brucella infection; 5 patients, Compression fracture of vertebrae; 2 patients, Eosinophilic granuloma of
vertebrae).
b Immunocompromised patients were deﬁned as those with underlying diseases such as malignancy, liver cirrhosis, and chronic renal failure,
or those receiving immunosuppressive treatment.17
Fig. 2 – (A–C) A 35-year-old man  with atypical spinal TB. (A) Lateral lumbar spine radiograph showed tumefaction of
paravertebral soft tissue. (B) A sagittal T2-weighted MRI  showed worm-eaten destruction of vertebral endplate at multiple
vertebral bodies (T11-L1), irregular abnormal signal in paravertebral soft tissue. (C) Axial MRI  showed formation of ﬁstula at
level of L2 vertebral body.
Table 2 – Clinical symptoms/signs and initial laboratory
ﬁndings of 29 atypical spinal TB patients.
Variables Value
Clinical symptoms
Fever  8(27.5%)
Weakness 12(41.4%)
Numbness 5(17.2%)
Night sweat 7(24.1%)
Malnutrition 5(17.2%)
Clinical signs
Back  pain 24(82.8%)
Radicular pain 6(20.7%)
Tenderness 10(34.5%)
Muscle atrophy 5(17.2%)
Hematological and biochemical data
C-reactive  protein (mg/L) 19.4 ± 7.9(5–35)
ESR  (mm/h) 24.8 ± 9.7(10–50)Clinical  diagnostic  value  of  the  ELISPOT  assay  for  atypical
spinal  TB
The ELISPOT was successfully performed on 61 enrolled sub-
jects.  The results are shown in Fig. 5. Out of 61 patients with
suspected  atypical spinal TB, 29 patients had positive ELISPOT
results.  The results of the various conventional diagnostic
tests  and the ELISPOT assay used to assess the samples from
61  patients with suspected atypical spinal TB are shown in
Table  3. We found that 37.5% of the patients had a positive
AFB  smear and 78.3% had a positive culture for M. tuberculo-
sis.  All patients with culture-conﬁrmed atypical spinal TB had
positive  ELISPOT results.
The  overall sensitivity, speciﬁcity, positive and neg-
ative  predictive values for atypical spinal TB diagnosis
by  the PPD skin test were 58.6%, 59.4%, 56.7% and
61.3%. By comparison, the sensitivity, speciﬁcity, posi-
tive  and negative predictive values for atypical spinal
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Fig. 3 – (A–C) A 5-year-old children with atypical spinal TB. (A) Lateral cervical vertebra radiograph showed bone destruction
and osteopenia of the C4 vertebral body. (B) CT scan showed irregular lesions at the C4 vertebral body and swelling in
paravertebral soft tissues. (C) C4 vertebral body had high signal on the T2-weighted image and the involved vertebral body
was  osteolysis or wedging. (D–F) A 60-year-old woman  with atypical spinal TB. (D) Lateral lumbar spine radiograph showed
T11 was  slightly wedging. (E), (F) MRI  showed an isolated slightly concentric collapse of the T11 vertebral body. The
adjoining disk spaces were  preserved.
Table 3 – Diagnostic yields of various tests in 29 patients with atypical spinal TB.
Diagnostic test n (positive)/n(total) Sensitivity(%)
PPD skin testa
Induration size ≥ 5 mm after 72 h 17/29 58.6
Induration size ≥10 mm after 72 h 11/29 37.9
Induration size ≥15 mm after 72 h 4/29 13.8
Antibody detection testb 18/29 62.1
Results of diagnostic tests for spinal tuberculosis
Granuloma with/without necrosis from biopsy samplec 23/26 88.5
Positive AFB smear from biopsy sample 9/24 37.5
Positive M. tuberculosis culture from biopsy sample 18/23 78.3
ELISPOT assay on PBMC 24/29 82.8
Data are presented as number positive/number tested unless otherwise indicated.
ELISPOT, enzyme-linked immunospot; PBMC, peripheral mononuclear cells; AFB, acid-fast bacilli.
a ELISPOT vs PPD skin test (total positive rate): p = 0.043, df = 1, 2 = 4.077.
b ELISPOT vs antiboby test (total positive rate): p = 0.078, df = 1, 2 = 3.107.
c ELISPOT vs histopathology detection (total positive rate): p = 0.549, df = 1, 2 = 0.359.
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Fig. 4 – (A–C) A 21-year-old man  with atypical spinal TB. (A) Lateral thoracic vertebra radiograph showed irregular lesions at
the T7–10 vertebral body. (B), (C) MRI  showed slight lesions at the upper and lower edges of T7–10 vertebral body. L3
vertebral body accessories had high signal on T2-weighted images. (D–F) A 45-year-old man  with atypical spinal TB. (D) MRI
showed multiple abscesses in extradural intraspinal canal at C1-T3 without identiﬁable osseous lesion. (E), (F) MRI  showed
multiple paravertebral abscesses at L1-S2 without identiﬁable osseous lesion.
Fig. 5 – This ﬁgure showing representative results of the ELISPOT assay from two patients. The upper lane (A) showed a
negative result from a non-TB disease patient. The lower lane (B) showed a positive result from an atypical spinal TB patient.
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Table 5 – Agreement between PPD skin test, antiboby
detection test, histopathology detection and ELISPOT
assay in 29 patients with atypical spinal TB.
Diagnostic test Agreement (%) Kappa p-Value
ELISPOT vs PPD skin test 68.9 0.300 0.054
ELISPOT vs Antiboby
detection  test
72.4 0.345 0.033
ELISPOT vs 88.5 0.506 0.009
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In this study, we  found that age and malnutrition wereHistopathology
detection
B diagnosis by the ELISPOT assay were 82.8%, 81.3%,
0.0% and 83.9%, respectively. The overall sensitivity of
he  ELISPOT assay was  higher than that of PPD skin test
p  < 0.05).
The comparison of the ELISPOT assay with the conven-
ional diagnostic tests is showed in Tables 4 and 5. Of the 23
atients  with atypical spinal TB who had positive histopatho-
ogical  examination 21 showed positive ELISPOT results. When
e  assessed the agreement between the histopathology detec-
ion  and the ELISPOT assay using the к  coefﬁcient, we  found
oderate agreement between the two tests (к  = 0.506).
actors  associated  with  the  ELISPOT  results  in  atypical
pinal  TB
able 6 shows clinical factors associated with number of SFC
nd  positivity of the ELISPOT assay among the 29 patients
ith  atypical spinal TB. The diagnostic sensitivity of the
LISPOT  assay in atypical spinal TB patients with normal
utrition (serum total protein: ≥50 g/L) was  higher (90.9%)
han  those with malnutrition (serum total protein: <50 g/L)
57.1%).  Likewise, the diagnostic sensitivity of the ELISPOT
ssay  in age-group <60 years was  higher (85.2%) than among
hose  aged ≥ 60 years (50.0%). The number of SFC and pos-
tivity  rate of the ELISPOT assay were not inﬂuenced by
ex,  course of disease, coexisting diseases and lymphocyte
ount.
iscussion
uberculosis (TB), more  prevalent in immunocompromised
ersons, is an emerging international problem despite
dvances in the methods of diagnosis and treatment; it
s  still prevalent in developing countries and is on the
ise  in the developed ones.18,19 In addition to the most
ommon manifestation-pulmonary TB, atypical spinal TB
lso  comprised a small proportion of extrapulmonary TB.
linically,  atypical spinal TB usually presents in a slowly
ndolent manner with nonspeciﬁc clinical presentations mak-
ng  the diagnosis a great challenge for physicians. Deﬁnite
iagnosis is generally considered to require microbiologi-
al conﬁrmation; however, the bacteriological gold-standard
esult, including solid media-based culture techniques using
owenstein–Jensen slants and Middlebrook 7H10/7H11 agar
nd  liquid media-based methods, such as with the BACTEC
60  MGIT system, usually takes several weeks to become
vailable. These may  lead to delay in diagnosis and initia-
ion of treatment. In some atypical forms of the disease, this3;1 7(5):529–537  535
may  have disastrous consequences. Therefore, rapid, sensi-
tive  and speciﬁc diagnostic tests for atypical spinal TB are
required.
The  ELISPOT assay is a rapid test, which only takes two
days  and has been used in the diagnosis of extrapulmonary
TB,13,14 including skeletal TB, TB pleurisy, intestinal TB, cuta-
neous  TB.11,12,20–22 We  performed this study to evaluate the
usefulness of the ELISPOT assay in diagnosing atypical spinal
TB.  In this study, we found that the sensitivity of the ELISPOT
for  diagnosing atypical spinal TB was  82.8%, which was  higher
than  that of PPD skin test, AFB smear and M. tuberculosis cul-
ture  from biopsy samples. In Taiwan, Lai et al.11 found that
the  ELISPOT had a sensitivity of 86.7% for diagnosing skele-
tal  TB (sensitivity of 100% for diagnosing spinal TB). In Korea,
Cho  et al.12 found that the sensitivity of the ELISPOT for active
osteoarticular TB (including 15 spinal TB patients) was  100%.
Despite  the limited sample size of the present work, this is the
ﬁrst  study to speciﬁcally evaluate the diagnostic performance
of  the ELISPOT assay for atypical spinal TB. These ﬁndings
indicate that the ELISPOT assay is a useful adjunct to current
tests  for diagnosis of atypical spinal TB.
Spinal TB in early stage has no speciﬁc features on radio-
logical image,  so plain radiography is of little help unless
the  collapse of disk margin or vertebra body appears. CT
scan  is valuable in revealing bony destruction and paraspinal
abscesses formation. MRI is more  sensitive in diagnosing
spinal TB. It can detect abnormal bone marrow with a low
signal  on T1-weighted images as well as a high signal on
T2-weighted images which cannot be detected by radio-
graphs  and CT scans.23,24 However, in case of inﬂammation
of the vertebral body without any obvious deformity or cold
abscess,  the diagnostic value of MRI was  very limited. In this
study,  three patients presented concentric collapse of single
body  without destruction of adjacent vertebral bodies and
intervertebral disk. Among these three patients, there was
no  history of exposure to TB, no pulmonary tuberculosis,
recent weight loss, low-grade fever, decreased appetite and
night  sweats. Laboratory examinations such as ESR and CRP
were  within the normal range. Mantoux test was  nonconclu-
sive.  The results of MRI combined PET-CT prompted spinal
tumor.  Nevertheless, the results of the ELISPOT assay were
positive  in these three patients. At last, the three patients
underwent invasive procedures to obtain a tissue specimen
for  diagnosic purposes. Histological analysis of fast frozen
section demonstrated a chronic granulomatous inﬂammation
with  caseation, a character of tuberculosis. In this series,
26  patients with mycobacterial infection underwent inva-
sive  procedures to obtain a tissue specimen for diagnostic
purposes, and 23 (88.5%) of these patients had histopathologic
features consistent with a diagnosis of TB infection. Among
these  23 patients, positive ELISPOT results were  found in 21
patients.  Although the sample size is too small to make a solid
conclusion,  this ﬁnding suggests that the use of the ELISPOT
assay,  a relatively less invasive but sensitive tool, appears
to  be used as a complementary method in the diagnosis of
atypical  spinal TB in clinical settings.associated with ELISPOT positivity in atypical spinal TB
patients.  Among these 29 patients with atypical spinal TB,
there  were  three children aged less than 5 years. Only one
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Table 4 – Comparsion of 29 patients with atypical spinal TB detected by PPD skin test, antiboby detection test,
histopathology detection, and ELISPOT.
PPD skin testa Antibody detection testb Histopathology detectionc
+ − Total + − Total + − Total
ELISPOT+ 16  8 24 17 7 24 21 1 22
ELISPOT– 1 4 5 1 4 5 2 2 4
Total 17 12 29 18 11 29 23 3 26
Table 6 – Factors associated with number of SFC and positivity rate of ELISPOT among the 29 patients with atypical spinal
TB.
Number of cases ELISPOT assay
ESAT-6 peptides CFP-10 peptides Positive rate
SFC pa SFC pa No. of positive (positive rate) pb
Sex
Male 15 22.7 ± 21.2 0.451 32.1 ± 31.6 0.983 13 (86.7%) 0.564
Female 14 20.4 ± 21.9 33.0 ± 34.5 11 (78.6%)
Age (years)
<60 27 22.0 ± 21.6 0.709 33.4 ± 33.1 0.542 23(85.2%) 0.019
≥60 2 16.0 ± 19.8 20.5 ± 27.6 1 (50.0%)
Course of disease (months)
<6  9 24.0 ± 28.8 0.835 37.0 ± 37.5 0.835 7 (77.8%) 0.634
≥6 20 20.6 ± 17.6 30.5 ± 30.8 17 (85.0%)
Coexisting diseases
No  22 22.4 ± 22.9 0.980 29.9 ± 28.9 0.672 19 (86.4%) 0.362
Yes 7 19.1 ± 15.8 40.6 ± 43.3 5 (71.4%)
Lymphocyte count (cell/mm3)
<1000 5 20.8 ± 17.4 0.978 47.2 ± 48.3 0.556 4 (80.0%) 0.858
≥1000 24 21.8 ± 22.2 29.5 ± 28.6 20 (83.3%)
Serum total protein (g/L)
<50  7 11.9 ± 14.1 0.062 20.4 ± 23.7 0.199 4 (57.1%) 0.039
≥50 22 24.7 ± 22.4 36.4 ± 34.3 20 (90.9%)
SFC, Spot-forming cells.
Data  are number of subjects.
tion
s.a Mann–Whitney U test was used to compare nonparametric distribu
b Pearson 2 test was used to compare the positive rate of two group
child had a positive ELISPOT result. Previous studies also
demonstrated that the ELISPOT assay had a sensitivity of
80–90%  for the diagnosis of pediatric tuberculosis. A sub-
stantial  proportion of young children with clinical and/or
microbiologic evidence of active TB had negative ELISPOT
assay  results.25,26 The clinical utility of the ELISPOT for
elderly patients with atypical spinal TB was  not clear, because
only  two patients aged more  than 60 years were enrolled
in  our study. Likewise, The diagnostic sensitivity of the
ELISPOT  assay in atypical spinal TB patients with normal
nutrition (serum total protein: ≥50 g/L) was  higher than that
of  atypical spinal TB patients with malnutrition (serum total
protein:  <50 g/L). Four of seven atypical spinal TB patients
with  malnutrition had false-negative ELISPOT results. A
potential  mechanism could underlie this ﬁnding. Severe
wasting disease or malnutrition causes unhealthy emaciation
with  extremely low serum total protein, debilitating the
patients  and also suppressing systemic immune response.27
Hang et al., also found that emaciation was  a risk factor for
false-negative result of ELISPOT assay.28 These risk factors of the SFC (mean ± SD).
might  result in a somewhat disappointing sensitivity for the
ELISPOT  assay in our study.
In  the present work, six (18.6%) of 32 patients with posi-
tive  ELISPOT results did not have active TB. This result can
be  explained by the following reason. The ELISPOT assay can
detect  latent TB infection (LTBI) as well as active TB, but it
cannot  differentiate LTBI from active TB. Therefore, a positive
ELISPOT  assay result might be due to LTBI. The inability of this
test  to discriminate active TB from LTBI might limit its applica-
tion  in the detection of active TB, especially in countries with
a  high prevalence of TB, such as China. Patients with LTBI are
expected  to have a positive ELISPOT assay.
This study had several limitations. First, we  did not assess
the  immune function of atypical spinal TB patients so that we
could  discuss the relationship between sensitivity of this assay
and  the features of T lymphocyte subsets in atypical spinal
TB  patients, because only a limited number of immunocom-
promised patients were enrolled in this study. Thus, further
studies  are needed to assess the diagnostic performance of
ELISPOT  assay in immunocompromised patients. Second, the
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tuberculosis. Am J Respir Crit Care Med. 1998;157:679–91.b r a z j i n f e c t d i s .
mall sample size of atypical spinal TB patients limited the
eliability  of sensitivity estimates for the ELISPOT assay, and
urther  large-scale studies are needed to clarify its diagnostic
alue  in this disease category.
In conclusion, the ELISPOT assay appears to be a useful
upplementary tool for diagnosing atypical spinal TB.
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